Press release
Sinofn Group Achieves PKU Milestone: EnRuiYou and EnBoYou Pass FSMP Registration Review
On November 21, 2025, Sinofn Group achieved a significant R&D milestone: its two FSMP (Foods for Special Medical Purposes) products dedicated to Phenylketonuria (PKU) - EnRuiYou and EnBoYou - officially passed the Chinese FSMP national registration onsite inspection.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/1-13.jpg
This successful review is not only an authoritative certification of product quality but also carries profound industry and market significance. It marks Sinofn Group's fulfillment of its solemn commitment to provide "allage" PKU nutrition solutions, achieving full lifecycle coverage from infancy to adulthood. Importantly, it breaks the longstanding monopoly of foreign brands in this field and elevates the company's strategic positioning in medical nutrition.
Building a Full LifeCycle Management System for PKU Patients
Sinofn Group has now established a scientific management system covering PKU patients across all age groups:
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/2-8.jpg
AGE GROUP
PRODUCT
FOCUS
Infants (0-12 months)
EnRuiYou
FSMP for amino acid metabolism disorders in infants
Children (1-10 years)
EnBoYou
FSMP tailored for amino acid metabolism disorders in children
Adolescents & Adults (10+ years)
EnZhuoYou + PKU lowprotein series
Specialized lowprotein formulas for longterm PKU management
These three phenylalaninefree FSMP powders are scientifically formulated based on Sinofn's years of professional nutrition management experience. Their core mission is to ensure that PKU children can enjoy a healthy and joyful start in life, just like their peers.
Strong Capabilities Driving Quality and Innovation
Behind this achievement lies Sinofn Group's:
*
Robust independent R&D capacity
*
Internationalstandard manufacturing systems
*
Rigorous and precise quality inspection capabilities
During the review, the company's scientific research, production compliance, and quality control were highly recognized by the expert panel. This demonstrates that Sinofn not only meets the strict regulatory standards for FSMP but also has the ability to consistently and stably supply highquality products such as EnRuiYou and EnBoYou.
By safeguarding the health and quality of life of rare disease patients, Sinofn Group is leading the way for domestic FSMP innovation and development, marking a new chapter in China's medical nutrition journey.
Media Contact
Company Name: Sinofn (Tianjin) Pharm-Tech Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sinofn-group-achieves-pku-milestone-enruiyou-and-enboyou-pass-fsmp-registration-review]
Phone: 022-24928910
Address:No. 60 Weiliu Road, Airport Zone
City: Tianjin, 300308
Country: China
Website: https://www.sinofnhealth.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sinofn Group Achieves PKU Milestone: EnRuiYou and EnBoYou Pass FSMP Registration Review here
News-ID: 4291976 • Views: …
More Releases from ABNewswire
SEO Agency Dubai: How Data-Driven Search Strategies Are Shaping Digital Growth
Explore how a data-driven SEO agency in Dubai helps businesses grow online through advanced search strategies, analytics, and performance-based SEO. Visit us today!
Dubai's digital economy is moving fast, and visibility has become a decisive factor in growth. Businesses competing in saturated markets can no longer rely solely on paid ads. They need organic authority, credibility, and long-term discoverability. This is where an SEO agency Dubai [https://www.google.com/search?SEO+agency+Dubai&kgmid=/g/11v3f6wqbl] businesses trust becomes essential,…
The Life and Loves of an Artist Illuminates the Remarkable Journey Behind a Life …
Authors Paul and Gail King present The Life and Loves of an Artist. This sweeping biographical narrative traces the extraordinary story of a family whose lives were intertwined with art, resilience, and history.
Rooted in meticulous research and personal reflection, the book offers a moving portrait of two generations shaped by both hardship and inspiration.
Purpose of the Book
What started as an attempt to remember family memories became a vivid journey of…
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 20 …
Key players operating in the Alzheimer's disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Prilenia Therapeutics, Denali Therapeutics Inc., Stemedica Cell Technologies, Inc., along with several other emerging and established companies.
The Alzheimer's disease market was valued at approximately USD 3,610 million…
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and …
Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox Ophthalmics, Sylentis, Envisia Therapeutics, Ocuphire Pharma, TearClear, Peregrine Ophthalmic, and others.
The Glaucoma Market across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,…
More Releases for Sinofn
SINOFN Appointed Sub-Center for Birth Defect Prevention
SINOFN Group Named Sub: Center of National Engineering Laboratory for Birth Defect Prevention
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-12/cover1.jpg
On December 24, 2020, the second council meeting of the National Engineering Laboratory for Key Technologies in Birth Defect Prevention was held in Beijing, followed by the first expert committee meeting the next day. The event brought together leading figures in maternal and child health, including Wang Qiaomei from the National Health Commission, Academician Qiang Boqin of…
HBIF Beijing 2025 Exhibition Walk Through | Sinofn Group Onsite Highlights
Event Overview
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/understanding-modern-art-4.jpg
On November 13-14, 2025, Sinofn Group participated in the Health Business Innovation Forum (HBIF) Beijing Station, booth B6. The Health Brand Marketing & Innovation Application Forum concluded successfully, showcasing Sinofn's diversified product solutions designed to flexibly meet the needs of product development.
Exhibition Highlights
Sinofn Group focused on scientific nutrition solutions across multiple health segments:
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/640-7.jpg
SEGMENT
SOLUTIONS PRESENTED
Weight Management
From meal replacements to functional supplements, offering multidimensional approaches.
Women's Health
Nutrition solutions for beauty…
SINOFN to Showcase Functional Foods at AAES 2025
The 16th AAES 2025 [AAES Natural Health Products Exhibition & AAES Natural Health Products Industry Conference], together with the 2nd Homology of Medicine and Food | Tonic Upgrading Development Summit, will be held from October 24-26, 2025 at the Nanjing International Exhibition Center (Xinzhuang), China.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-10/176049515765781279.jpg
The event is expected to attract 260+ exhibitors and more than 7,000 professional visitors from across the nutrition and health industry.
SINOFN (Tianjin) Pharmaceutical Technology Co.,…
New Nutrition Business | Award 2023 won by SINOFN
SINOFN Wins "Nutrition Solutions Pioneer" at 2023 New Nutrition "Nutrition Intelligent Manufacturing" Awards
On October 19, 2023, SINOFN was honored with the prestigious "Nutrition Solutions Pioneer Award" at the 2023 New Nutrition "Nutrition Intelligent Manufacturing" Awards ceremony in Guangzhou. Hosted by New Nutrition, New Plant, and Nutrition Box, and strategically co-organized by the Guangdong Health Food Industry Association, the event drew over 600 industry leaders to celebrate outstanding contributions across the…
How Supplement Powder Is Made: Inside SINOFN Factory
Powdered supplements - from protein shakes to greens blends - are a staple in the nutrition industry. But what really happens before that fine, flavorful powder lands in your shaker bottle?
At Sinofn Health, we follow a precise, science‐driven process to ensure every batch is safe, potent, and consistent. Here's a behind‐the‐scenes look at how we turn raw ingredients into premium powdered supplements.
Why Powdered Supplements Are So Popular
Powdered supplements have surged…
SINOFN Health: China Top Nutrition Supplements Manufacturer
The global wellness industry is undergoing a profound transformation, and at its heart is a shifting focus towards preventative health and personalized nutrition. In this dynamic landscape, a company's ability to innovate, ensure quality, and adapt to consumer needs is paramount. Standing out as a China Top Nutrition Supplements Manufacturer(https://www.sinofnhealth.com/), SINOFN (Tianjin) Pharm-Tech Co., Ltd. is not just a participant but a leader, setting new benchmarks for research-driven excellence and…
